Skip to content
value.today

Rythm Health, Inc.

Total raised
$56 M
3 rounds on record
Latest round
$31 M
Jun 2026
First round on record
May 2025
Today
Private
No later event on record

Funding rounds

3 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Rythm Health, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Jun 2026$31 MNo. 3$10 to $50 million

Rythm Health, Inc.: Raise no. 3, Jun 2026

Investors in this round

8 investors had bought by the notice of Jun 18, 2026: 8 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$31 M of $31 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Dacri Burdan · Executive Officer, Director, Promoter
  • Robert Wade · Executive Officer, Director, Promoter
  • Andrew Goletka · Director
  • Michael Smith · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “Total offering amount and total amount sold include value of exchanged secondary shares.”

Signed by Robert Wade, Chief Executive Officer. Newest notice filed Jun 18, 2026. Read the notice at the SEC.

equitySEC
Oct 2025$19 MNo. 2$10 to $50 million

Rythm Health, Inc.: Raise no. 2, Oct 2025

Investors in this round

18 investors had bought by the notice of Nov 13, 2025: 18 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$19 M of $21 M offered; $1 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Dacri Burdan · Executive Officer, Director, Promoter
  • Robert Wade · Executive Officer, Director, Promoter
  • Andrew Montgomery · Director
  • Michael Smith · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “Total offering amount and total amount sold includes value of SAFEs converted to equity as well as value of exchanged secondary shares.”

Signed by Robert Wade, Chief Executive Officer. Newest notice filed Nov 13, 2025. Read the notice at the SEC.

equitySEC
May 2025$5 MNo. 1$2 to $10 million

Rythm Health, Inc.: Raise no. 1, May 2025

Investors in this round

27 investors had bought by the notice of Jun 17, 2025: 27 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$5 M of $5 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Dacri Burdan · Executive Officer, Director, Promoter
  • Robert Wade · Executive Officer, Director, Promoter
  • Andrew Montgomery · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “Total offering amount and total amount sold includes value of SAFEs converted to equity.”

Signed by Robert Wade, Chief Executive Officer. Newest notice filed Jun 17, 2025 (1 amendment). Read the notice at the SEC.

equitySEC

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Rythm Health, Inc. chose not to state its revenue in its newest notice of a funding round (Jun 2026).

    SEC Form D · Jun 2026

  • The industry group it chose in its notices: Other Health Care.

    SEC Form D · Jun 2026

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Rythm Health, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Rythm Health, Inc.
NameRoleNamed in
Dacri BurdanExecutive officerJun 2026
Robert WadeExecutive officerJun 2026
Andrew GoletkaDirectorJun 2026
Dacri BurdanDirectorJun 2026
Michael SmithDirectorJun 2026
Robert WadeDirectorJun 2026
Andrew MontgomeryDirectorNov 2025
Dacri BurdanPromoterJun 2026
Robert WadePromoterJun 2026